Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France
NCT02981901 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 376
Last updated 2018-08-23
Summary
No structured organization for ovarian first line management emerges in France. Management across France seems to depend on regional contexts.
Regions display no specific organization or delineate regional network for the ovarian cancer management or report centralized management revolving around referent centers. These different templates present a major problem in identifying differences, costs and benefit.
To deal with this issue the Investigators propose a health economic evaluation based on cost-effectiveness analyses, completed with a budget impact analysis. This study will investigate the cost-effective management of patients with initial ovarian cancer using databases representative of different parts of French territories.
Conditions
- Ovarian Epithelial Cancer
Interventions
- OTHER
-
Patient with ovarian epithelial cancer
Sponsors & Collaborators
-
Cancer Côte d'or registry
collaborator UNKNOWN -
Cancer Calvados registry
collaborator UNKNOWN -
Centre Leon Berard
lead OTHER
Principal Investigators
-
Isabelle RAY-COQUARD, PU-PH · Centre Leon Berard
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- France
Study Locations
More Related Trials
-
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
NCT06085456 ·Status: RECRUITING
-
A Cohort Establishment Study of Total Management of Ovarian Cancer
NCT06018935 ·Status: RECRUITING
-
Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
NCT03220932 ·Status: UNKNOWN ·Phase: PHASE3
-
Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer
NCT03754569 ·Status: COMPLETED ·Phase: NA
-
Platino-resistance in Ovarian Cancer
NCT03954171 ·Status: RECRUITING ·Phase: NA
-
A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
NCT02591095 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents
NCT01947296 ·Status: COMPLETED
-
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
NCT03159572 ·Status: COMPLETED
-
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
NCT05574673 ·Status: RECRUITING
-
Search for Predictors of Therapeutic Response in Ovarian Carcinoma
NCT01391351 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
NCT05204342 ·Status: COMPLETED
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Centralization and Oncologic Outcomes in Ovarian Cancer
NCT07075939 ·Status: ACTIVE_NOT_RECRUITING
-
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
NCT06385912 ·Status: COMPLETED
-
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NCT06084195 ·Status: RECRUITING ·Phase: NA
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.
NCT04573933 ·Status: COMPLETED
-
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer
NCT06216496 ·Status: RECRUITING ·Phase: NA
-
Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
NCT06588322 ·Status: RECRUITING ·Phase: NA
-
Registry Platform Ovarian and Endometrial Cancer
NCT05129969 ·Status: RECRUITING
-
Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
NCT05500391 ·Status: RECRUITING ·Phase: PHASE2
-
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR
NCT04295577 ·Status: COMPLETED
-
Ovarian Cancer Radiomics Approach in CT Led Evaluation
NCT06817174 ·Status: RECRUITING
-
Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss
NCT03027479 ·Status: COMPLETED ·Phase: NA
-
Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients
NCT04152941 ·Status: COMPLETED